Not Yet Recruiting NA INTERVENTIONAL 2-arm
NCT07470580
Radiofrequency Ablation Versus Adrenalectomy for Adenoma in Patients With Primary Aldosteronism and Hypertension (ADERADHTA2)
Radiofrequency Ablation Versus Adrenalectomy for Adenoma in Patients With Primary Aldosteronism and Hypertension: a Multicentre Prospective Randomized Study
Sponsor: University Hospital, Toulouse
Conditions
Adrenalectomy Primary Aldosteronism Due to Conn Adenoma Radiofrequency Ablation Treatment
Interventions
Adrenalectomy RFA -radiofrequency ablation
Updated 1 time since 2026 Last updated: Mar 10, 2026 Started: Apr 1, 2026 Primary completion: Apr 1, 2030 Completion: Apr 1, 2030
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A NA clinical study on Adrenalectomy and Primary Aldosteronism Due to Conn Adenoma, this trial is actively recruiting participants. The trial is conducted by University Hospital, Toulouse and has accumulated 1 data snapshot since 2026. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
1 version recorded Not Yet Recruiting — NA
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- University Hospital, Toulouse
Data source: University Hospital, Toulouse
For direct contact, visit the study record on ClinicalTrials.gov .